It’s surprising, to say the least, to see a company go from zero information to efficacy nod, because, well, what are you basing your efficacy on? How did you recruit your patients and veterinary partners to help you with efficacy? Did you make them all sign some incredibly airtight NDAs?
I suspect that the answer for “what are they basing efficacy on” is “animal testing on dogs”, and that’s also why you’re not hearing them announce the specifics to the general public.
I mean … how else are you supposed to test a novel treatment for dogs? I don’t have a good sense for the space, but my prior is higher on silence-given-no-testing than silence-given-tests-on-the-eventual-target here. If they had tests on dogs that showed significant results, I’d expect the headline/pitch/whatever to be “Double the remaining lifespan of your dog!” or something.
I suspect that the answer for “what are they basing efficacy on” is “animal testing on dogs”, and that’s also why you’re not hearing them announce the specifics to the general public.
I mean … how else are you supposed to test a novel treatment for dogs? I don’t have a good sense for the space, but my prior is higher on silence-given-no-testing than silence-given-tests-on-the-eventual-target here. If they had tests on dogs that showed significant results, I’d expect the headline/pitch/whatever to be “Double the remaining lifespan of your dog!” or something.
I agree that that’s the only realistic way. That doesn’t mean I expect it to be popular or something Loyal wants to draw attention to.